Pharmaceutical Executive
An overview of Orphan Reinsurer and Benefit Managers groups, including potential challenges with the model and various model suggestions.
Michael Ciarametaro
Advertisement
Articles by Michael Ciarametaro
Advertisement
Latest Updated Articles
Improving Management of Gene and Cell TherapiesSeptember 10th 2018
Advertisement
Advertisement
Trending on PharmExec
1
Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors
2
Executive Order Cuts Recommended Childhood Vaccines Down to 11: Report
3
BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies
4
The Science of Targeting Multiple Immune Components in ITP: Q&A with Dr. Srikanth Nagalla
5